-
Pierce Brosnan and Helen Mirren on the joys of filming 'MobLand'
-
'Now or Never': Ethiopia influencers push for Eritrea invasion
-
S.African activists push back on data centre rush
-
Mbappe furore rages on in China, but Mao comments censored
-
Judges set to rule on Australian mushroom killer's appeal
-
Billionaire Ambani's Jio jumps 21% in market debut after record India IPO
-
Syria reopens Jordan border crossing after mending ties
-
Rays win thriller to thwart Brewers in World Series
-
Cyclone Arnab lashes India coast, no deaths reported
-
Reigning champ Knicks earn first win against Pistons
-
Trump tamed after US midterms? Europe doubts it
-
Runners swap streets for shopping malls as haze chokes Singapore
-
Tech stocks soar as SK hynix adds to rising AI confidence
-
Billionaire Ambani's Jio to debut after record India IPO
-
Sri Lanka's Tamil farmers fight to reclaim land after civil war
-
UK set for cautious budget as borrowing costs climb
-
Afghans compete for jobs, homes as millions return
-
Anthropic's record IPO faces some big questions
-
'They don't care about us': Trump food aid cuts leave Americans struggling and angry
-
US Fed expected to hold rates steady ahead of key midterm elections
-
Meta, Snap head to trial in another case about social media's harms
-
Can this Latin Grammy-winner help Democrats win back Congress?
-
French Senate passes bill to make protesters pay for unrest damage
-
Tuvalu has 'limited' power to halt its fossil fuel investments: NZ govt papers seen by AFP
-
India evacuates tens of thousands as Cyclone Arnab makes landfall
-
Palestinian activist Khalil returns to Columbia after US detention
-
In tight Israel vote, both camps hold out cautious hope
-
Trump drastically loosens oil and gas methane rules
-
AI chip giant SK hynix says quarterly operating profit soars 630%
-
French Senate weighs bill to make protesters pay for unrest damage
-
Youths testify about 'despair' in unprecedented Canadian climate trial
-
'A very sad day': Arteta despair as Arsenal stunned by Fleetwood
-
Syria, Jordan agree to mend ties after deadly strike
-
Charles tackles thorny legacy of slavery on Caribbean trip
-
Arsenal stunned by fourth-tier Fleetwood in League Cup
-
Former Grand Slam winner Wawrinka ends tennis career
-
Last-gasp Sabitzer strike sends Dortmund past Bremen in German Cup
-
Brazil's Flavio Bolsonaro flees to US after election loss
-
Rights groups reject Emirati diplomat for UN top job
-
'Faerie' nights: 'ACOTAR' fans finally get their book
-
Flavio Bolsonaro headed to US after Brazil election defeat: US media
-
American woman convicted of getting military training from Islamic State
-
Alcaraz and Zverev win Vienna openers
-
Israel opposition holds narrow edge over Netanyahu in first projections
-
Tech firms gain ahead of Fed decision, results from AI giants
-
Floriani hits maiden goal as Lazio go top
-
Syria condemns deadly Jordan strikes as 'unacceptable violation'
-
Trump set to drastically loosen oil and gas sector's methane rules
-
England's Fin Smith in race against time to face Australia
-
Storied Paris department store seeks bankruptcy protection
Animal testing put to the test in Swiss vote
Switzerland goes to the polls Sunday to decide whether animal and human testing should be banned -- a proposal that has triggered an outcry in a country heavily reliant on big pharma.
Opinions suggest that the proposal by animal rights defenders is highly unlikely to pass.
But if it did, "Switzerland would be the only country internationally with such a ban," said Yves Fluckiger, president of the Swiss universities lobby group.
Researchers insist that medical progress is impossible without experimentation.
At the University of Geneva, Patrycja Nowak-Sliwinska, head of the molecular pharmacology laboratory, unveils her cell incubator where intestinal organoids from cancer patients are being cultivated.
These structures, made up of cells, make it possible to test a large number of potential treatments.
"With the in vitro model, we try to find promising candidates" -- and only the latter would then be tested on animals, said Nowak-Sliwinska, who received a prize rewarding researchers who work to replace animals with other methods.
But even she said it would be impossible to do all the research without animal experimentation and clinical trials.
This is why the university's Faculty of Medicine has an animal facility in the basement housing some 25,000 animals -- mostly mice and rats.
- Strict protocols -
Inside, Professor Doron Merkler conducts research to find a treatment for a form of multiple sclerosis.
The research could not advance without using mice, into which he injects modified cells to observe how the disease affects the nervous system.
The mouse he is working on is showing symptoms: instability, difficulty moving, and partial paralysis of the limbs.
The experiments are framed by a strict protocol regarding their degree of severity, and animal keepers are trained to detect when an animal is not well.
"If no veterinary care can be provided to the animal, we can decide with the researcher to sacrifice it," said Pierre Bonnaventure, head of animal facilities at the faculty.
In Switzerland, researchers seeking to use live animals must make a formal request, establish that there is no alternative method available and that the conditions imposed on the animals will be as light as possible.
The number of animals used has consequently fallen sharply, from nearly two million per year in the early 1980s to around 560,000.
Some 20,000 animals a year undergo severe interventions, such as the implantation of a tumour, according to federal authorities.
- Proposal 'goes too far' -
Under Switzerland's direct democracy system, campaigners collected enough signatures to trigger a popular vote.
The proposal would outlaw experiments not only on animals but on humans too, as well as ban the importation of new drugs developed through such means.
"Animal experiments should be considered a crime," Renato Werndli, a doctor among those who launched the initiative, told AFP.
All the major political parties in Switzerland are against the proposal.
For the government, the ban "goes too far" and would have "serious consequences for health" -- and also for the economy, in a country where the chemical and pharmaceutical sector represents just over half of all exports.
Interpharma, the Swiss pharmaceutical industry's lobby group, warned that in the event of a ban, "the institutions and companies concerned would be forced to relocate their activities abroad".
Switzerland has already rejected three initiatives on the subject -- in 1985 (70 percent), 1992 (56 percent) and 1993 (72 percent) -- and is expected to do likewise this time.
But it remains to be seen whether the majority will be as big, in a society where animal welfare has grown in importance.
For Samia Hurst, a bioethicist at the University of Geneva, the new initiative commits "a fairly frequent mistake, which is to target biomedical research".
However, she told AFP: "Animal experimentation, among the various uses that humanity makes of other species, is both the most closely monitored and undoubtedly the most justified."
F.Müller--BTB